Technology transfer is valuable in many different contexts.
- In response to epidemics: for the detection and characterization of SARS-CoV2 variants during the recent pandemic.
- Within the scope of a clinical research project: for tests to characterize pathogens, or for molecular typing of S. pneumoniae and M. tuberculosis.
- As part of an operational research project: to assess the performance and cost-effectiveness of a test (e.g. prognostic biomarkers) or evaluate a comprehensive screening and treatment strategy for an infectious disease (e.g. screening tools).